DOBBS Community and OncoCare have joined forces to strengthen cancer awareness, early detection and access to appropriat...
South Korea-based startup NeuroXT Inc., a medical device manufacturer, has announced that NEXT-Cue, its AI-based Softwar...
As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...
South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that its ...
Viome Life Sciences has signed a Memorandum of Understanding (MoU) with Druk Holding & Investments Ltd (DHI), the in...
Singapore is hosting the Global Alliance for Genomics and Health (GA4GH) 14th Plenary meeting from 28 September to 2 Oct...
US-based Mayo Clinic Laboratories and Pathology Asia Holdings (PAH), based in Singapore, have announced a stra...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that...
Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced ...
A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cance...
South Korea-based Crescom, a company specialising in musculoskeletal medical artificial intelligence (AI), has signed a ...
US-based Pillar Biosciences, Inc., LC-SCRUM-Asia and LSI Medience Corporation have announced a collaboration to support ...
Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced the launch o...
UK-based Optellum and South Korea's Coreline Soft have announced their intent to collaborate across geographie...
For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
Co-Diagnostics, Inc., a US-based molecular diagnostics company with a unique, patented platform for the development of m...
Japan's Global Health Innovative Technology (GHIT) Fund has announced an investment of JPY 140 million (approximately $8...
As Malaysia confronts a significant surge in Tuberculosis (TB) cases, with over 3,100 confirmed infections recorded in t...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
Virax Biolabs has announced that its wholly owned subsidiary, Virax Biolabs (UK) has entered into an exclusive multi-cou...
